High-quality biomanufacturing for animal health—from R&D to regulatory approval.
At Elise Biopharma, we provide contract development and manufacturing services specifically tailored for the growing field of veterinary biologics. Whether you’re developing a next-generation animal vaccine, a recombinant enzyme therapy, or species-specific antibody fragments, our microbial and mRNA platforms offer the scalability and speed you need to move from preclinical studies to global regulatory approval.
Animal health products face many of the same challenges as human biologics—plus species-specific biology, pricing pressure, and varying global standards. Our team is equipped to help you navigate this complexity with high-efficiency production, cost-effective process design, and support for USDA, EMA, and CVM submission requirements.
With Elise, you’re not just outsourcing veterinary manufacturing—you’re building a smart, compliant pipeline that’s ready for field trials, licensing, and commercial launch.
A Trusted Partner for Animal Health Innovators
The veterinary biologics market is expanding rapidly, from livestock disease prevention to pet health innovations and companion animal therapeutics. We work with companies across the spectrum, including:
- Animal health startups developing novel protein-based or RNA-based vaccines for livestock, poultry, or aquaculture
- Biotech companies working on monoclonal or polyclonal antibodies for dogs, cats, horses, or exotics
- Ag-bio and feed supplement developers formulating bioactives and enzymes for gut health, nutrition, or disease resistance
- Global pharma players outsourcing microbial or mRNA process development for veterinary lines
- Academic or veterinary colleges seeking high-quality production for translational projects or veterinary trials
At Elise, we provide full CDMO support to bring your veterinary innovations to life with speed, scale, and regulatory alignment.
Veterinary Biologics CDMO Services
Microbial Expression of Species-Specific Biologics
Our microbial platforms are ideal for scalable production of:
- Species-specific antigens for vaccine candidates
- Recombinant proteins and enzymes for therapeutic or nutritional use
- VHH nanobodies and antibody fragments tailored to companion animals
We offer E. coli, Pichia, and custom strain support with emphasis on purity, immunogenicity, and lot consistency.
Learn more about our VHH Nanobodies and services here —–> VHH Nanobodies for Animal Health
Formulation Support for Injectable & Oral Delivery
Different species, delivery routes, and therapeutic goals require tailored formulations. We assist with:
- Injectables for subcutaneous or intramuscular use in livestock and pets
- Oral delivery for enzymes, prebiotics, or vaccine delivery via feed/water
- Stability testing across temperature and storage conditions
- Lyophilized, emulsion, or capsule formats where needed
We can optimize viscosity, solubility, and pH for your target species and administration route.
Scaled Supply for Field Trials & Commercialization
We help you scale from R&D to field-ready lots:
- Bench-scale (2L, 10L) and pilot (50–200L) fermentation
- Bulk formulation for multi-site field trials
- Lot-to-lot consistency and full release testing
- Commercial readiness planning and supply forecasts
Our teams coordinate timelines and material availability with your field and study teams to ensure smooth deployment.
Cross-Species QC Method Development
Veterinary biologics often target less-characterized species. We support:
- Custom assay development for species-specific potency, binding, or activity
- Method qualification for unique host species
- In-house ELISA, SDS-PAGE, and endotoxin profiling
- Guidance on matrix effects and interference from feed or serum
Our analytical team collaborates closely with yours to define appropriate QC for both efficacy and regulatory acceptance.
Regulatory Dossier Support (USDA, EMA, CVM)
Veterinary biologics face complex and fragmented global regulations. Elise provides:
- CMC documentation aligned with USDA APHIS, EMA, and FDA CVM frameworks
- Data and process support for conditional licensure
- Traceability and QMS documentation for VICH guidelines
- Tech transfer support for commercial fill/finish or distribution partners
We ensure your manufacturing process is defensible, documented, and ready for regulatory scrutiny.
Why Veterinary Companies Choose Elise Biopharma
Animal health clients partner with us because we combine:
- Technical expertise in microbial and mRNA platforms
- Flexible infrastructure that scales as your program matures
- Affordable CDMO models that align with veterinary pricing constraints
- Species-aware problem solving across livestock, pets, and exotic animals
- Global regulatory literacy, from APHIS to CVM to EMA
Whether you’re building a recombinant swine vaccine, a probiotic for aquaculture, or a feline biologic, we’re here to help you scale the right way—with cost, species, and global markets in mind.
Let’s Advance Animal Health—Together
Veterinary biologics are no longer secondary to human innovation. They’re becoming a core driver of biotech value, animal welfare, and global health. Elise Biopharma is ready to support your veterinary pipeline with the same scientific depth, quality systems, and responsive engagement we bring to every human therapeutic program.